Fracture Risk Down With Osteoporosis Drug in Metastatic Prostate Cancer

By News Health
1 day Ago

(MedPage Today) — Fractures associated with androgen deprivation therapy (ADT) for metastatic prostate cancer decreased significantly in men who received a bisphosphonate in addition to standard of care (SOC), data from a large randomized trial…

Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/116646

Author :

Publish date : 2025-07-23 21:05:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

I've Spent My Life Fighting for Kids' Health, and I Won't Stop Now

Cardiovascular Risks Resurface Old Concerns About Sulfonylureas for T2D

What Happened to Our Brains During the Pandemic?

FDA 'Expert Panels' Raise Concerns of Evading Regulations, Ethics

Why Trump's order targeting 'woke' AI may be impossible to follow

Your Moves Might Reflect Your Longevity